Optima Medical Innovations Corp.
TOKIF
$0.00
$0.000.00%
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Revenue | 1.94M | 1.91M | 4.70M | 4.61M | 7.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.94M | 1.91M | 4.70M | 4.61M | 7.16M |
| Cost of Revenue | 1.55M | 1.46M | 3.47M | 3.23M | 5.23M |
| Gross Profit | 392.10K | 457.60K | 1.23M | 1.38M | 1.93M |
| SG&A Expenses | -419.70K | -251.70K | 2.42M | 2.88M | 5.97M |
| Depreciation & Amortization | 582.10K | 623.80K | 652.90K | 691.20K | 884.80K |
| Other Operating Expenses | -150.80K | -150.80K | -150.80K | -- | -- |
| Total Operating Expenses | 1.59M | 1.74M | 6.49M | 6.90M | 12.18M |
| Operating Income | 347.10K | 170.40K | -1.80M | -2.29M | -5.02M |
| Income Before Tax | -365.30K | -471.10K | -3.51M | -4.22M | -16.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.37 | -0.47 | -3.51 | -4.22 | -16.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -365.30K | -471.10K | -3.51M | -4.22M | -16.70M |
| EBIT | 347.10K | 170.40K | -1.80M | -2.29M | -5.02M |
| EBITDA | 841.00K | 700.20K | -1.22M | -1.65M | -4.36M |
| EPS Basic | -0.01 | -0.01 | -0.07 | -0.09 | -0.37 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.04 | -0.05 | -0.08 |
| EPS Diluted | -0.01 | -0.01 | -0.07 | -0.09 | -0.37 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.04 | -0.05 | -0.08 |
| Average Basic Shares Outstanding | 202.52M | 202.10M | 199.97M | 194.53M | 188.31M |
| Average Diluted Shares Outstanding | 202.52M | 202.10M | 199.97M | 194.53M | 188.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
